MINK THERAPEUTICS INC's ticker is and the CUSIP is 603693102. A total of 22 filers reported holding MINK THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $88,549 | -48.6% | 80,499 | -1.9% | 0.00% | – |
| Q2 2023 | $172,262 | +737.4% | 82,029 | +655.6% | 0.00% | – |
| Q1 2023 | $20,572 | -24.9% | 10,856 | +3.4% | 0.00% | – |
| Q4 2022 | $27,410 | +30.5% | 10,502 | +5.0% | 0.00% | – |
| Q3 2022 | $21,000 | +110.0% | 10,005 | +50.7% | 0.00% | – |
| Q2 2022 | $10,000 | -75.0% | 6,639 | -62.4% | 0.00% | – |
| Q1 2022 | $40,000 | -13.0% | 17,644 | +69.7% | 0.00% | – |
| Q4 2021 | $46,000 | – | 10,399 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sofinnova Investments, Inc. | 345,499 | $1,541,000 | 0.09% |
| Artal Group S.A. | 289,588 | $1,292,000 | 0.04% |
| Gyon Technologies Capital Management, LP | 42,448 | $189,000 | 0.04% |
| RTW INVESTMENTS, LP | 416,666 | $1,858,000 | 0.03% |
| VANGUARD GROUP INC | 10,771 | $48,000 | 0.00% |
| Ameritas Investment Partners, Inc. | 150 | $1,000 | 0.00% |
| UBS Group AG | 3,934 | $18,000 | 0.00% |
| AMERICAN INTERNATIONAL GROUP, INC. | 1,037 | $5,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 1,847 | $8,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 1,207 | $5,000 | 0.00% |